Trump signs order raising Canada tariffs to 35% from 25%
CHICAGO - CME Group, a leading derivatives marketplace with a market capitalization of $104.76 billion, has announced a record average daily volume (ADV) for May 2025, with 28.9 million contracts traded, marking an 11% increase from the previous year. This surge in trading activity was seen across various asset classes, including interest rates, metals, and cryptocurrencies. According to InvestingPro data, the company maintains excellent financial health with a "GREAT" overall score, supported by strong profit and momentum metrics.
The record May ADV for interest rates stood at 16.2 million contracts, while equity index contracts reached 6.6 million. The energy sector saw 2.6 million contracts traded, and agricultural contracts totaled 1.6 million. Notably, metals ADV hit a May record of 933,000 contracts, and cryptocurrency products reached a new high with an ADV of 197,000 contracts, representing a $10 billion notional value. This robust trading activity has contributed to CME’s impressive revenue growth of 11.73% over the last twelve months. InvestingPro subscribers can access 10+ additional key insights about CME’s performance and growth metrics.
A significant growth area within interest rates was the Secured Overnight Financing Rate (SOFR) futures, which experienced a 31% increase to 4 million contracts. U.S. Treasury futures and options also saw growth, with a 6% rise to 10.6 million contracts. Equity index products showed strong performance as well, with Micro E-mini Nasdaq 100 futures and Micro E-mini S&P 500 futures climbing 37% and 60% respectively.
The energy sector’s record May options ADV was 445,000 contracts, and metals saw a record monthly Micro Gold futures ADV of 347,000 contracts. In the rapidly expanding cryptocurrency space, Ether futures reached a record monthly ADV of 17,000 contracts, with Micro Ether futures surging 235% to 92,000 contracts, and Micro Bitcoin futures ADV jumping 95% to 65,000 contracts.
On an international level, ADV increased by 15% to 8.7 million contracts, with the Europe, Middle East, and Africa (EMEA) region up 14% to 6.4 million contracts and Asia up 24% to 2 million contracts. The BrokerTec U.S. Repo average daily notional value rose by 28.6% to $352 billion, and the EBS Spot FX average daily notional value grew by 27% to $67.8 billion.
This record-setting performance reflects the robust trading environment at CME Group, as it continues to offer a wide range of global benchmark products across major asset classes. The company’s stock is currently trading near its 52-week high, with a total return of over 50% in the past year. While CME appears to be trading slightly above its Fair Value according to InvestingPro analysis, the company has maintained dividend payments for 23 consecutive years. Investors seeking detailed analysis can access CME’s comprehensive Pro Research Report, available exclusively to InvestingPro subscribers, along with in-depth research on 1,400+ other US stocks.
In other recent news, CME Group has announced the upcoming launch of four new cryptocurrency reference rates and real-time indices, expanding its offerings to include Arbitrum, Ondo, NEAR, and Sui. This expansion, set for June 2025, aims to provide market participants with transparent pricing data for emerging digital assets. Erste Group has downgraded CME Group’s stock rating from Buy to Hold, citing an anticipated slowdown in turnover and net profit growth despite the expected rise in trading and hedging activities. In contrast, UBS has maintained its Buy rating with a $305 price target, expressing confidence in CME Group’s strategic direction and market resilience. Meanwhile, Argus Research has raised the price target for CME Group shares to $308, reflecting expectations of growth in contract volumes driven by economic and geopolitical conditions. The recent annual shareholder meeting saw the election of directors and the ratification of Ernst & Young LLP as the company’s independent public accounting firm for 2025. However, a quorum issue led to some directors continuing as holdovers. These developments highlight CME Group’s ongoing efforts to adapt to market demands and maintain its leadership in the financial marketplace.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.